MICHAEL JOHNSON to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Angiotensin Receptor Antagonists.
Connection Strength
0.941
-
Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
Score: 0.455
-
Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
Score: 0.335
-
Patterns of antihypertensive therapy among patients with diabetes. J Gen Intern Med. 2005 Sep; 20(9):842-6.
Score: 0.056
-
Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas. Patient Educ Couns. 2024 Feb; 119:108073.
Score: 0.049
-
A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes. Drugs Aging. 2023 04; 40(4):377-390.
Score: 0.047